The global integrated cardiology devices market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing number of patients suffering from cardiovascular diseases and the rising demand for minimally invasive procedures. Cardiology EMR software segment accounted for the largest share in 2018, followed by FFR and EHR segments. The Asia Pacific region is expected to witness fastest growth during the forecast period due to increasing awareness about cardiovascular diseases and growing healthcare infrastructure in emerging economies such as India and China.
-The global population is aging, which will lead to an increase in the number of people with heart disease.
-The increasing prevalence of obesity and diabetes will also lead to an increase in cardiovascular disease.
-There is a lack of trained cardiologists, which will lead to a shortage in the number of physicians available for treatment.
-Aging populations and increased prevalence rates for cardiovascular diseases are driving demand for new treatments and technologies that can improve patient outcomes.
Industry Growth Insights published a new data on “Integrated Cardiology Devices Market”. The research report is titled “Integrated Cardiology Devices Market research by Types (Cardiology EMR Software, EHR, FFR, Optical Coherence Tomography, Others), By Applications (Catheterization Laboratories, Hospitals, Others), By Players/Companies Medtronic (US), Boston Scientific Corporation (US), Jude Medical (US), Edwards Lifesciences Corporation (US), Abbott Laboratories (US), Johnson and Johnson (US), Getinge (Sweden), Terumo Corporation (Japan), Lepumedical (Bejing), Acrostak (Switzerland), Koninklijke Philips N.V. (Netherlands), Athenahealth, Inc. (U.S)”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Integrated Cardiology Devices Market Research Report
By Type
Cardiology EMR Software, EHR, FFR, Optical Coherence Tomography, Others
By Application
Catheterization Laboratories, Hospitals, Others
By Companies
Medtronic (US), Boston Scientific Corporation (US), Jude Medical (US), Edwards Lifesciences Corporation (US), Abbott Laboratories (US), Johnson and Johnson (US), Getinge (Sweden), Terumo Corporation (Japan), Lepumedical (Bejing), Acrostak (Switzerland), Koninklijke Philips N.V. (Netherlands), Athenahealth, Inc. (U.S)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Integrated Cardiology Devices Market Report Segments:
The global Integrated Cardiology Devices market is segmented on the basis of:
Types
Cardiology EMR Software, EHR, FFR, Optical Coherence Tomography, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Catheterization Laboratories, Hospitals, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic (US)
- Boston Scientific Corporation (US)
- Jude Medical (US)
- Edwards Lifesciences Corporation (US)
- Abbott Laboratories (US)
- Johnson and Johnson (US)
- Getinge (Sweden)
- Terumo Corporation (Japan)
- Lepumedical (Bejing)
- Acrostak (Switzerland)
- Koninklijke Philips N.V. (Netherlands)
- Athenahealth, Inc. (U.S)
Highlights of The Integrated Cardiology Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cardiology EMR Software
- EHR
- FFR
- Optical Coherence Tomography
- Others
- By Application:
- Catheterization Laboratories
- Hospitals
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Integrated Cardiology Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Integrated Cardiology Devices (ICDs) are medical devices that are used to diagnose and treat heart conditions. ICDs include devices such as pacemakers, defibrillators, and cardiac resynchronization therapy (CRT) machines.
Some of the major players in the integrated cardiology devices market are Medtronic (US), Boston Scientific Corporation (US), Jude Medical (US), Edwards Lifesciences Corporation (US), Abbott Laboratories (US), Johnson and Johnson (US), Getinge (Sweden), Terumo Corporation (Japan), Lepumedical (Bejing), Acrostak (Switzerland), Koninklijke Philips N.V. (Netherlands), Athenahealth, Inc. (U.S).
The integrated cardiology devices market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Integrated Cardiology Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Integrated Cardiology Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Integrated Cardiology Devices Market - Supply Chain
4.5. Global Integrated Cardiology Devices Market Forecast
4.5.1. Integrated Cardiology Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Integrated Cardiology Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Integrated Cardiology Devices Market Absolute $ Opportunity
5. Global Integrated Cardiology Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Integrated Cardiology Devices Market Size and Volume Forecast by Type
5.3.1. Cardiology EMR Software
5.3.2. EHR
5.3.3. FFR
5.3.4. Optical Coherence Tomography
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Integrated Cardiology Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Integrated Cardiology Devices Market Size and Volume Forecast by Application
6.3.1. Catheterization Laboratories
6.3.2. Hospitals
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Integrated Cardiology Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Integrated Cardiology Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Integrated Cardiology Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Integrated Cardiology Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Integrated Cardiology Devices Demand Share Forecast, 2019-2026
9. North America Integrated Cardiology Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Integrated Cardiology Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Integrated Cardiology Devices Market Size and Volume Forecast by Application
9.4.1. Catheterization Laboratories
9.4.2. Hospitals
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Integrated Cardiology Devices Market Size and Volume Forecast by Type
9.7.1. Cardiology EMR Software
9.7.2. EHR
9.7.3. FFR
9.7.4. Optical Coherence Tomography
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Integrated Cardiology Devices Demand Share Forecast, 2019-2026
10. Latin America Integrated Cardiology Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Integrated Cardiology Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Integrated Cardiology Devices Market Size and Volume Forecast by Application
10.4.1. Catheterization Laboratories
10.4.2. Hospitals
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Integrated Cardiology Devices Market Size and Volume Forecast by Type
10.7.1. Cardiology EMR Software
10.7.2. EHR
10.7.3. FFR
10.7.4. Optical Coherence Tomography
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Integrated Cardiology Devices Demand Share Forecast, 2019-2026
11. Europe Integrated Cardiology Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Integrated Cardiology Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Integrated Cardiology Devices Market Size and Volume Forecast by Application
11.4.1. Catheterization Laboratories
11.4.2. Hospitals
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Integrated Cardiology Devices Market Size and Volume Forecast by Type
11.7.1. Cardiology EMR Software
11.7.2. EHR
11.7.3. FFR
11.7.4. Optical Coherence Tomography
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Integrated Cardiology Devices Demand Share, 2019-2026
12. Asia Pacific Integrated Cardiology Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Integrated Cardiology Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Integrated Cardiology Devices Market Size and Volume Forecast by Application
12.4.1. Catheterization Laboratories
12.4.2. Hospitals
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Integrated Cardiology Devices Market Size and Volume Forecast by Type
12.7.1. Cardiology EMR Software
12.7.2. EHR
12.7.3. FFR
12.7.4. Optical Coherence Tomography
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Integrated Cardiology Devices Demand Share, 2019-2026
13. Middle East & Africa Integrated Cardiology Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Integrated Cardiology Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Integrated Cardiology Devices Market Size and Volume Forecast by Application
13.4.1. Catheterization Laboratories
13.4.2. Hospitals
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Integrated Cardiology Devices Market Size and Volume Forecast by Type
13.7.1. Cardiology EMR Software
13.7.2. EHR
13.7.3. FFR
13.7.4. Optical Coherence Tomography
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Integrated Cardiology Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Integrated Cardiology Devices Market: Market Share Analysis
14.2. Integrated Cardiology Devices Distributors and Customers
14.3. Integrated Cardiology Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic (US)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Boston Scientific Corporation (US)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Jude Medical (US)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Edwards Lifesciences Corporation (US)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Abbott Laboratories (US)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Johnson and Johnson (US)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Getinge (Sweden)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Terumo Corporation (Japan)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Lepumedical (Bejing)
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Acrostak (Switzerland)
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Koninklijke Philips N.V. (Netherlands)
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Athenahealth, Inc. (U.S)
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
